ALKS
Alkermes Plc
NASDAQ: ALKS · HEALTHCARE · DRUG MANUFACTURERS - SPECIALTY & GENERIC
$33.71
-1.26% today
Updated 2026-04-29
Market cap
$5.62B
P/E ratio
23.57
P/S ratio
3.81x
EPS (TTM)
$1.43
Dividend yield
—
52W range
$25 – $36
Volume
2.4M
WallStSmart proprietary scores
50
out of 100
Grade: C
Hold
Investment rating
3.3
Growth
D8.5
Quality
A7.0
Profitability
B+6.7
Valuation
B4/9
Piotroski F-Score
Moderate
2.6
Altman Z-Score
Grey zone
—
Industry rank
—
View all highly rated stocks (75+) →201 stocks currently score above 75
Price targets
Analyst target
$44.24
+31.24%
12-Month target
$28.21
-16.32%
Intrinsic (DCF)
$76.10
Margin of safety
+54.13%
3 Strong Buy12 Buy3 Hold0 Sell0 Strong Sell
Price chart
X-Ray snapshot
Strengths
+ Free cash flow $170.05M — positive
+ 54.13% below intrinsic value
+ Debt/equity 0.04x — low leverage
Risks
- Revenue declining -10.60% QoQ
Key financials
Revenue Net Income Free Cash Flow
| Metric | 2022 | 2023 | 2024 | 2025 | TTM |
|---|---|---|---|---|---|
| Revenue | $1.11B | $1.66B | $1.56B | $1.48B | $1.48B |
| Net income | $-158.27M | $355.76M | $367.07M | $241.66M | $49.34M |
| EPS | — | — | — | — | $1.43 |
| Free cash flow | $-17.21M | $353.31M | $405.64M | $480.33M | $170.05M |
| Profit margin | -14.24% | 21.39% | 23.57% | 16.37% | 16.40% |
Peer comparison
Smart narrative
Alkermes Plc trades at $33.71. representing a P/E of 23.57x trailing earnings. Our Smart Value Score of 50/100 indicates the stock is fair. The company scores 4/9 on the Piotroski F-Score. With an Altman Z-Score of 2.58, it sits in the grey zone. TTM revenue stands at $1.48B. with profit margins at 16.40%. Our DCF model estimates intrinsic value at $76.10.
Frequently asked questions
What is Alkermes Plc's stock price?
Alkermes Plc (ALKS) trades at $33.71.
Is Alkermes Plc overvalued?
Smart Value Score 50/100 (Grade C, Hold). DCF value $76.10.
What is the price target of Alkermes Plc (ALKS)?
The analyst target price is $44.24, representing +31.2% upside from the current price of $33.71.
What is the intrinsic value of Alkermes Plc (ALKS)?
Based on our DCF model, intrinsic value is $76.10, a +54.1% margin of safety versus $33.71.
What is Alkermes Plc's revenue?
TTM revenue is $1.48B.
Piotroski F-Score?
4/9 — moderate financial health.
Altman Z-Score?
2.58 — grey zone.
Company info
SectorHEALTHCARE
IndustryDRUG MANUFACTURERS - SPECIALTY & GENERIC
CountryUSA
ExchangeNASDAQ
CurrencyUSD
Quick metrics
P/S ratio3.81x
ROE14.70%
Beta0.39
50D MA$31.35
200D MA$30.14
Shares out0.17B
Float0.15B
Short ratio—
Avg volume2.4M
Performance
1 week—
1 month—
3 months—
YTD—
1 year—
3 years—
5 years—